Evidence map›Paper›PMID 37737589›Full record

ArticleMicrobiology spectrum2023

Unraveling

Ana P Pereira, Patrícia Antunes, Paula Bierge, Rob J L Willems, Jukka Corander, Teresa M Coque, Oscar Q Pich, Luisa Peixe, Ana R Freitas, Carla Novais and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. DecodingFrontiers in microbiology · 2024
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 6 countries.

Ana P PereiraUCIBIO-Applied Molecular Biosciences Unit, Laboratory of Microbiology, Faculty of Pharmacy, University of Porto , Porto, Portugal.ORCID 0000-0003-3470-253X
Patrícia AntunesUCIBIO-Applied Molecular Biosciences Unit, Laboratory of Microbiology, Faculty of Pharmacy, University of Porto , Porto, Portugal.ORCID 0000-0002-3553-2678
Paula BiergeLaboratori de Recerca en Microbiologia i Malalties Infeccioses, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona , Sabadell, Spain.
Rob J L WillemsDepartment of Medical Microbiology, University Medical Center Utrecht , Utrecht, the Netherlands.
Jukka CoranderDepartment of Biostatistics, Faculty of Medicine, University of Oslo , Oslo, Norway.
Teresa M CoqueServicio de Microbiologia, Hospital Universitario Ramón y Cajal , Madrid, Spain.
Oscar Q PichLaboratori de Recerca en Microbiologia i Malalties Infeccioses, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona , Sabadell, Spain.
Luisa PeixeUCIBIO-Applied Molecular Biosciences Unit, Laboratory of Microbiology, Faculty of Pharmacy, University of Porto , Porto, Portugal.
Ana R FreitasUCIBIO-Applied Molecular Biosciences Unit, Laboratory of Microbiology, Faculty of Pharmacy, University of Porto , Porto, Portugal.
Carla NovaisUCIBIO-Applied Molecular Biosciences Unit, Laboratory of Microbiology, Faculty of Pharmacy, University of Porto , Porto, Portugal.ORCID 0000-0002-3826-6731
from the ESCMID Study Group on Food- and Water-borne Infections (EFWISG)
Universidade do Porto · PTUniversitat Autònoma de Barcelona · ESCentro de Investigación Biomédica en Red · ESUniversity Medical Center Utrecht · NLUniversity of Helsinki · FI

Funding

EC | European Regional Development Fund (ERDF) NORTE-01-0145-FEDER-000041MEC | Fundação para a Ciência e a Tecnologia (FCT) 2022.02124.PTDC, UIDP/04378/2020, UIDB/04378/2020, LA/P/0140/2020MEC | Fundação para a Ciência e a Tecnologia (FCT) CEECIND/02268/2017MEC | Fundação para a Ciência e a Tecnologia (FCT) SFRH/BD/144401/2019MEC | Instituto de Salud Carlos III (ISCIII) FI20/00009MEC | Instituto de Salud Carlos III (ISCIII) MV22/00032
6 · The paper itself

Abstract

importanceDespite the increasing use of quaternary ammonium compounds (QACs), the susceptibility of pathogens to these antimicrobials remains largely unknown.

Indexed as

BacillotabiocidedisinfectionOne Health

Identifiers

PMID37737589
PMCPMC10581157
OpenAlexW4386944529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.